Eligibility for a compassionate use program typically depends on several factors:
1. The patient has a serious or immediately life-threatening condition. 2. No comparable or satisfactory alternative therapy options are available. 3. The patient is not eligible for participation in clinical trials. 4. The potential benefits of the investigational therapy outweigh the potential risks, as assessed by a qualified physician.